{"id":"W1980094335","doi":"10.1371/journal.pone.0072966","title":"EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute for Oil Sands Innovation, University of Alberta; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Universitätsspital Zürich; Centre Hospitalier Universitaire Vaudois","keywords":"Erlotinib; KRAS; Epidermal growth factor receptor; Lung cancer; Bevacizumab; Exon; Erlotinib Hydrochloride; Cancer research; Medicine; Gefitinib; Biomarker; EGFR inhibitors; Cancer; Biology; Oncology; Internal medicine; Gene; Colorectal cancer; Chemotherapy; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004046433,0.000163122,0.0003056396,0.0004684776,0.00007620516,0.0003340721,0.0001228458,0.0002804443,0.0005293402],"category_scores_gemma":[0.0009365745,0.00007737391,0.000121068,0.0003393126,0.0001232595,0.000159721,0.0001212259,0.0002318895,0.0001168172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001720917,"about_ca_system_score_gemma":0.0001012947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000358349,"about_ca_topic_score_gemma":0.0006023504,"domain_scores_codex":[0.9997903,0.00006948319,0.0000181024,0.00004857527,0.00005046508,0.00002316931],"domain_scores_gemma":[0.999607,0.0001613224,0.0001332186,0.00002085466,0.00004848732,0.00002905589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004948619,0.0002276702,0.7332502,0.0001058534,0.000204383,0.0002879177,0.00008196941,0.00171379,0.2143617,0.000132481,0.0002723393,0.04441306],"study_design_scores_gemma":[0.00002740396,0.0007961421,0.9576827,0.000008763745,0.0001320996,0.0006776387,0.00004186559,0.004111506,0.03554905,0.0001731799,0.0007916388,0.000008035149],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979911,0.0007505973,0.0006128761,0.000031585,0.000004442972,0.000008741113,0.0002120264,0.00001535569,0.00037331],"genre_scores_gemma":[0.9988807,0.0000989143,0.000516945,0.0000213679,0.000003999929,0.00000815262,0.000246741,0.000002391603,0.0002207751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005293402,"threshold_uncertainty_score":0.002139986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0372568101852567,"score_gpt":0.294213648767592,"score_spread":0.2569568385823353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}